The clinical consequences of cancer-mediated bone destruction represent a significant ... with multiple myeloma and at least one osteolytic lesion. The drug of choice at the present time in ...
Peer-reviewed 2-year follow up clinical data published in 2023 on ZetaMet™ (Zeta-BC-003) demonstrated resolution of 7 lytic lesions (radiated ... breast cancer to bone and soft tissues which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback